- Home
- FDMT vs GNFT Comparison
FDMT vs GNFT Comparison
Compare FDMT & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- GNFT
- Stock Information
- Founded
- FDMT 2013
- GNFT 1999
- Country
- FDMT United States
- GNFT France
- Employees
- FDMT N/A
- GNFT N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FDMT Health Care
- GNFT Health Care
- Exchange
- FDMT Nasdaq
- GNFT Nasdaq
- Market Cap
- FDMT 192.2M
- GNFT 186.3M
- IPO Year
- FDMT 2020
- GNFT 2019
- Fundamental
- Price
- FDMT $6.61
- GNFT $3.88
- Analyst Decision
- FDMT Buy
- GNFT Strong Buy
- Analyst Count
- FDMT 9
- GNFT 2
- Target Price
- FDMT $30.63
- GNFT $11.00
- AVG Volume (30 Days)
- FDMT 733.0K
- GNFT 3.7K
- Earning Date
- FDMT 08-11-2025
- GNFT 09-22-2025
- Dividend Yield
- FDMT N/A
- GNFT N/A
- EPS Growth
- FDMT N/A
- GNFT N/A
- EPS
- FDMT N/A
- GNFT 0.03
- Revenue
- FDMT $33,000.00
- GNFT $73,187,701.00
- Revenue This Year
- FDMT $9,921.62
- GNFT $5.15
- Revenue Next Year
- FDMT N/A
- GNFT N/A
- P/E Ratio
- FDMT N/A
- GNFT $125.53
- Revenue Growth
- FDMT N/A
- GNFT 105.01
- 52 Week Low
- FDMT $2.24
- GNFT $2.55
- 52 Week High
- FDMT $17.41
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- FDMT 57.82
- GNFT 45.28
- Support Level
- FDMT $5.97
- GNFT $3.84
- Resistance Level
- FDMT $7.33
- GNFT $4.40
- Average True Range (ATR)
- FDMT 0.48
- GNFT 0.13
- MACD
- FDMT -0.11
- GNFT -0.04
- Stochastic Oscillator
- FDMT 39.51
- GNFT 4.83
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.